Bionomics Research and Development Expenses 2022-2024 | NEUP
Bionomics research and development expenses from 2022 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Bionomics Annual Research and Development Expenses
(Millions of US $) |
| 2024 |
$9 |
| 2023 |
$13 |
| 2022 |
$12 |
| 2021 |
$4 |
Bionomics Quarterly Research and Development Expenses
(Millions of US $) |
| 2024-09-30 |
$2 |
| 2024-06-30 |
|
| 2023-12-31 |
|
| 2023-09-30 |
$3 |
| 2023-06-30 |
|
| 2022-12-31 |
|
| 2022-06-30 |
|
| 2021-06-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.007B |
$0.000B |
|
Bionomics Limited is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders. Bionomics Limited is based in ADELAIDE, Australia.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
| Kidpik (PIKM) |
United States |
$0.000B |
0.00 |
